Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Design Therapeutics (DSGN) Research & Development (2020)

Historic Research & Development for Design Therapeutics (DSGN) over the last 1 years, with Q4 2020 value amounting to $2.7 million.

  • Design Therapeutics' Research & Development changed N/A to $2.7 million in Q4 2020 from the same period last year, while for Dec 2020 it was $6.1 million, marking a year-over-year change of. This contributed to the annual value of $6.1 million for FY2020, which is N/A changed from last year.
  • Design Therapeutics' Research & Development amounted to $2.7 million in Q4 2020.
  • Design Therapeutics' 5-year Research & Development high stood at $2.7 million for Q4 2020, and its period low was $377000.0 during Q1 2020.